Mainstream genetic testing for high-grade ovarian, tubal and peritoneal cancers: A tertiary referral centre experience.

The Australian & New Zealand journal of obstetrics & gynaecology(2023)

引用 1|浏览8
暂无评分
摘要
Mainstreamed genetic testing is feasible, with an acceptable TAT, ensuring adequate opportunity to inform treatment decisions. Tumour testing and inclusion of moderate-risk cancer predisposition genes in mainstreaming represent potential pathways that will require further exploration.
更多
查看译文
关键词
BRCA,genetic testing,mainstreaming,ovarian tubal and peritoneal cancer,pathogenic variants
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要